April 24, 2018 / 12:34 PM / 5 months ago

BRIEF-Suven Life Sciences Says FDA Observed Some Procedures Are Deficient During Medak Unit Inspection

April 24 (Reuters) - Suven Life Sciences Ltd:

* SUVEN LIFE SCIENCES - FDA DURING INSPECTION OF PASHAMYLARAM, MEDAK UNIT OBSERVED THERE ARE PROCEDURES FOLLOWED ON CERTAIN ASPECTS WHICH ARE DEFICIENT

* SAYS CO REVISED STANDARD OPERATING PROCEDURES AS CORRECTIVE ACTION Source text - bit.ly/2HW47sz Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below